711 (Mesalamine Delayed-Release 1.2 g)
Pill with imprint 711 is Brown, Elliptical / Oval and has been identified as Mesalamine delayed-release 1.2 g. It is supplied by Zydus Pharmaceuticals (USA) Inc..
Mesalamine is used in the treatment of ulcerative colitis; crohn's disease; inflammatory bowel disease; ulcerative colitis, maintenance; crohn's disease, maintenance (and more), and belongs to the drug class 5-aminosalicylates. Excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 1.2 g is not a controlled substance under the Controlled Substance Act (CSA).
Images for 711
- 1.2 g
- Elliptical / Oval
- Prescription only
- Drug Class:
- Pregnancy Category:
- B - No proven risk in humans - excluding Asacol and Asacol HD
C - Risk cannot be ruled out - Asacol and Asacol HD
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Zydus Pharmaceuticals (USA) Inc.
- National Drug Code (NDC):
More about mesalamine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 263 Reviews – Add your own review/rating
- Drug class: 5-aminosalicylates
- Mesalamine rectal
- Mesalamine Long-Acting Capsules (Delzicol)
- Mesalamine Tablets
- Mesalamine Long-Acting Capsules (Apriso)
- ... +5 more
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.